Verona Pharma

United Kingdom
Newdigate, England, United Kingdom, SE1 1LB

Company profile

Verona Pharma company profile

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough. The company creates therapies to address unmet medical requirements in the treatment of respiratory disorders. Verona Pharma was established in 2005 by Clive Page in London, England.

Business identity

Contact email
[email protected]
Phone number
+44 20 7863 3300
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2005-01-01, Year

Headquarters

Postal code
SE1 1LB
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
8
Total equity funding
$277.1M
Last funding
Post IPO Debt / $450M / 2024-05-09
Last equity funding
Post IPO Equity
Investors
32
Lead investors
5
Articles
316
Exited on
2006-09-19

Founders and investors

Lead investors

Henderson Global InvestorsOaktree Capital ManagementOxford Finance LLCRA Capital ManagementSilicon Valley Bank

Investors

Andera PartnersNew Enterprise AssociatesRA Capital ManagementSamsara BioCapitalVivo Capital